Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicus Pharma Ltd (TSE:MDCX)
TSXV:MDCX
RESEARCH TOOLSreports
Holding TSE:MDCX?
Track your performance easily
MDCX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$1.60 - C$7.60
Previous CloseC$6.58
Volume1.50K
Average Volume (3M)1.71K
Market Cap
C$65.29M
Enterprise ValueC$62.73M
Total Cash (Recent Filing)C$2.94M
Total Debt (Recent Filing)C$375.03K
Price to Earnings (P/E)―
Beta8.68
Next Earnings
Aug 22, 2024EPS Estimate
-C$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.91
Shares Outstanding10,846,780
10 Day Avg. Volume1,980
30 Day Avg. Volume1,710
Standard Deviation1.33
R-Squared0.35
Alpha-0.20
Financial Highlights & Ratios
Price to Book (P/B)11.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medicus Pharma Ltd News
PremiumCompany Announcements
Medicus Pharma Prepares for U.S. Market EntryPremiumCompany Announcements
Medicus Pharma Launches Phase 2 Skin Cancer Trial
PremiumCompany Announcements
Medicus Pharma Advances Skin Cancer Treatment
PremiumCompany Announcements
Medicus Pharma Ltd. Raises Funds and Converts Notes
PremiumCompany Announcements
Medicus Pharma Boosts Capital with Share Sale and Notes ConversionPremiumCompany Announcements
Medicus Pharma Pursues US IPO for Market Expansion
PremiumCompany Announcements
Medicus Pharma Completes Initial Private Placement
PremiumCompany Announcements
Medicus Pharma Launches Convertible Note OfferingOptions Prices
Currently, No data available
---
Ownership Overview
MDCX FAQ
What was Medicus Pharma Ltd’s price range in the past 12 months?
Medicus Pharma Ltd lowest stock price was C$1.60 and its highest was C$7.60 in the past 12 months.
What is Medicus Pharma Ltd’s market cap?
Currently, no data Available
When is Medicus Pharma Ltd’s upcoming earnings report date?
Medicus Pharma Ltd’s upcoming earnings report date is Aug 22, 2024 which is 83 days ago.
How were Medicus Pharma Ltd’s earnings last quarter?
Medicus Pharma Ltd released its earnings results on May 30, 2024. The company reported -C$0.22 earnings per share for the quarter, beating the consensus estimate of -C$0.36 by C$0.14.
Is Medicus Pharma Ltd overvalued?
According to Wall Street analysts Medicus Pharma Ltd’s price is currently Overvalued.
Does Medicus Pharma Ltd pay dividends?
Medicus Pharma Ltd does not currently pay dividends.
What is Medicus Pharma Ltd’s EPS estimate?
Medicus Pharma Ltd’s EPS estimate is -C$0.22.
How many shares outstanding does Medicus Pharma Ltd have?
Medicus Pharma Ltd has 9,923,138 shares outstanding.
What happened to Medicus Pharma Ltd’s price movement after its last earnings report?
Medicus Pharma Ltd reported an EPS of -C$0.22 in its last earnings report, beating expectations of -C$0.36. Following the earnings report the stock price went down -5.195%.
Which hedge fund is a major shareholder of Medicus Pharma Ltd?
Currently, no hedge funds are holding shares in TSE:MDCX
---
Medicus Pharma Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Medicus Pharma Ltd
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company focused on investing in novel life sciences and bio-technology companies through Food and Drug Administration (FDA) approved clinical trials. The Company identifies, acquires and advances relatively de-risked clinical stage assets through clinical development and commercialization. The Company is exploring to expand its drug development pipeline through acquisitions and partnerships. The Company, through its subsidiary, SkinJect, Inc., is focused on the development of a drug delivery system using novel dissolvable microneedle arrays for the treatment of certain skin cancers. SkinJect is a novel, minimally invasive treatment for common forms of non-melanoma skin cancer, basal cell and squamous cell carcinoma.
---
Technical Analysis
---